SCHEMBL5388127

SCHEMBL5388127

CCC(C)c1cc(N)ccc1-c1ccc(N)cc1C(C)CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.41
ANPEP P15144 1/20 0.39
ALDH1A1 P00352 6/20 0.39
GAA P10253 4/20 0.39
HSD17B10 Q99714 3/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 2/20 0.39
USP2 O75604 1/20 0.39
PKM P14618 1/20 0.39
RORC P51449 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
MAPK1 P28482 1/20 0.36
PTPRC P08575 2/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249358 0.83 ALDH1A1 (0.43) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL9006035 0.82 PTPRC (0.53) TSHRANPEPALDH1A1GAAHSD17B10
SCHEMBL12444685 0.82 ALDH1A1 (0.46) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL5382824 0.82 RORC (0.58) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL842248 0.80 GAA (0.44) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL5377207 0.80 TSHR (0.38) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL1772000 0.79 GAA (0.43) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL2154295 0.78 ANPEP (0.47) TSHRANPEPALDH1A1GAAHSD17B10
SCHEMBL10882492 0.78 ALDH1A1 (0.46) TSHRALDH1A1GAAHSD17B10HPGD
SCHEMBL20794059 0.77 MAPT (0.54) TSHRALDH1A1GAAUSP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202359-B2 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2007-04-10 US disclosed
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2005-04-21 US disclosed
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 TSHR 4548/4885ANPEP 2070/4885ALDH1A1 81/4885
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 TSHR 4491/4885ANPEP 1622/4885ALDH1A1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.